The IN.PACT Admiral device will provide a new treatment option for PAD patients.
Human factors engineering and the tools companies can leverage will get way more sophisticated.
The process gives sponsors the ability to interact more with FDA.
The agency’s latest draft guidance is part of its strategy in creating a national evaluation system for medical devices.
A new treatment option is now available for patients who are candidates for an angioplasty and prefer an absorbable device to a permanent metallic stent.
Having the right internal material science expertise, along with aligning material specs with device outcomes is essential.
The cognitive app that aims to make daily diabetes management easier and more informative is in the final development stage.
A roundtable discussion on key issues that medtech companies face in product development.
Conducting usability tests will help manufacturers reduce the risk of harmful use errors and enhance device effectiveness.
Start-up Ariste Medical has developed technology to reduce surgical site infections and transform implants into combination products.